Patent · US Active

Lipocationic dendrimers and uses thereof

US12024486B2 · kind B2 · utility

0Cited by

6References

26Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Daniel J. SIEGWART · Dallas, US
Kejin ZHOU · Dallas, US

Key dates

Filing date	Jun 15, 2023
Grant date	Jul 2, 2024
Priority date	—
Expiry date	Jun 15, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/15
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modular dendrimers with cationic groups and lipophilic groups are provided herein. In some aspects, the dendrimers provided herein may be formulated in compositions which contain a nucleic acid and one or more helper excipients. In some aspects, these compositions may also be used to treat diseases or disorders with a therapeutic nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.